• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic Function.ALBI评分作为肝细胞癌分期和治疗规划的新工具：ALBI分级在肝功能通用评估中的优势
Liver Cancer. 2017 Nov;6(4):377-379. doi: 10.1159/000481212. Epub 2017 Oct 19.
2
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.使用白蛋白-胆红素分级对极早期肝细胞癌患者射频消融治疗后的肝功能评估
Dig Dis Sci. 2017 Nov;62(11):3235-3242. doi: 10.1007/s10620-017-4775-8. Epub 2017 Oct 5.
3
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.白蛋白-胆红素分级对2584例日本肝细胞癌患者预后评估的价值
J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250.
4
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.不可切除肝细胞癌患者重复经动脉化疗栓塞术期间的肝功能及引入索拉非尼后的预后：多中心分析
Dig Dis. 2017;35(6):602-610. doi: 10.1159/000480256. Epub 2017 Oct 17.
5
Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma.改良白蛋白-胆红素-TNM 评分作为评估肝细胞癌患者预后模型的验证
World J Hepatol. 2019 Jun 27;11(6):542-552. doi: 10.4254/wjh.v11.i6.542.
6
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.作为日本肝脏学会肝癌循证临床实践指南一部分的白蛋白-胆红素（ALBI）分级：与肝损伤及Child-Pugh分级的比较
Liver Cancer. 2017 Jun;6(3):204-215. doi: 10.1159/000452846. Epub 2017 Mar 9.
7
Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.结合白蛋白-胆红素分级的改良CLIP评分在接受经动脉化疗栓塞治疗的HBV相关肝细胞癌患者中保留了预后价值。
J Cancer. 2018 Jun 14;9(13):2380-2388. doi: 10.7150/jca.22925. eCollection 2018.
8
Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.将白蛋白-胆红素分级纳入意大利肝癌项目系统用于肝细胞癌。
J Gastroenterol Hepatol. 2017 Jan;32(1):221-228. doi: 10.1111/jgh.13457.
9
Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score.验证白蛋白-吲哚菁绿评估模型在接受肝切除术的肝细胞癌患者中的应用，并与白蛋白-胆红素评分进行比较。
J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):51-57. doi: 10.1002/jhbp.597. Epub 2019 Jan 16.
10
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.基线ALBI分级对接受乐伐替尼治疗的肝细胞癌患者预后的影响：一项多中心研究
Cancers (Basel). 2019 Jul 7;11(7):952. doi: 10.3390/cancers11070952.

引用本文的文献

1
ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma.ALBI-肌少症评分作为肝细胞癌治疗结果的预测指标
Sci Rep. 2025 Apr 26;15(1):14621. doi: 10.1038/s41598-025-97295-7.
2
Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy.乐伐替尼给药前蛋白尿对阿替利珠单抗联合贝伐单抗治疗后疗效的影响。
JGH Open. 2025 Jan 19;9(1):e70098. doi: 10.1002/jgh3.70098. eCollection 2025 Jan.
3
Proton beam stereotactic body radiotherapy and hypofractionated therapy with pencil beam scanning is safe and effective for advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A single center experience.质子束立体定向体部放射治疗及笔形束扫描低分割治疗对晚期肝细胞癌和肝内胆管癌安全有效：单中心经验
J Radiosurg SBRT. 2023;9(1):43-52.
4
Preoperative ALBI grade predicts mortality in patients undergoing curative surgery for pancreatic head cancer.术前 ALBI 分级可预测胰头癌根治性手术患者的死亡率。
Medicine (Baltimore). 2023 Sep 8;102(36):e35069. doi: 10.1097/MD.0000000000035069.
5
Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma.基于列线图的预测模型：用于评估自发性破裂肝细胞癌患者 30 天和 1 年生存率。
BMC Cancer. 2022 Nov 15;22(1):1177. doi: 10.1186/s12885-022-10290-3.
6
An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study.基于 mALBI-Child-Pugh 的列线图预测巨大肝细胞癌患者肝切除术后 B-C 级肝衰竭的多中心研究。
World J Surg Oncol. 2022 Jun 16;20(1):206. doi: 10.1186/s12957-022-02672-5.
7
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.利福昔明治疗日本肝性脑病患者的长期疗效和安全性：一项多中心回顾性研究
J Clin Med. 2022 Mar 12;11(6):1571. doi: 10.3390/jcm11061571.
8
The Combination of Albumin-Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child-Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria.白蛋白-胆红素评分与凝血酶原时间相结合是预测 Child-Pugh A 级肝细胞癌患者经动脉化疗栓塞术后肝功能障碍的有用工具，纳入标准最多为七条。
J Clin Med. 2021 Oct 21;10(21):4838. doi: 10.3390/jcm10214838.
9
MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.MELD-Sarcopenia 优于 ALBI 和 MELD 评分在等待肝移植的肝细胞癌患者。
Asian Pac J Cancer Prev. 2021 Jul 1;22(7):2005-2009. doi: 10.31557/APJCP.2021.22.7.2005.
10
Anti-Programmed death-1 therapy in advanced hepatocellular carcinoma: A real-world experience.晚期肝细胞癌的抗程序性死亡-1治疗：一项真实世界经验
Clin Case Rep. 2021 Feb 20;9(4):2162-2167. doi: 10.1002/ccr3.3970. eCollection 2021 Apr.

本文引用的文献

1
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.白蛋白-胆红素分级在日本46681例肝细胞癌患者全国性调查中的验证、潜力及预后评估：对肝功能进行更详细评估的必要性
Liver Cancer. 2017 Nov;6(4):325-336. doi: 10.1159/000479984. Epub 2017 Sep 22.
2
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.作为日本肝脏学会肝癌循证临床实践指南一部分的白蛋白-胆红素（ALBI）分级：与肝损伤及Child-Pugh分级的比较
Liver Cancer. 2017 Jun;6(3):204-215. doi: 10.1159/000452846. Epub 2017 Mar 9.
3
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.在终末期肝病模型（MELD）时代，ALBI和PALBI分级可预测不同治疗方式和巴塞罗那临床肝癌（BCLC）分期的肝细胞癌患者的生存率。
J Gastroenterol Hepatol. 2017 Apr;32(4):879-886. doi: 10.1111/jgh.13608.
4
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.白蛋白-胆红素分级对2584例日本肝细胞癌患者预后评估的价值
J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250.

ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic Function.

作者信息

Hiraoka Atsushi, Michitaka Kojiro, Kumada Takashi, Kudo Masashi

机构信息

Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.

Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.

出版信息

Liver Cancer. 2017 Nov;6(4):377-379. doi: 10.1159/000481212. Epub 2017 Oct 19.

DOI:10.1159/000481212
PMID:29234641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5704723/
Abstract
摘要